Management ChangeJul 9, 2026, 09:41 AM
FibroBiologics Appoints Dr. Kathleen Rubins to Board
AI Summary
FibroBiologics, Inc. announced a change to its Board of Directors. Matt Link resigned from the Board, effective July 2, 2026. Subsequently, on July 8, 2026, the Board appointed Dr. Kathleen Rubins as a Class III director. Dr. Rubins, a retired NASA astronaut and microbiologist, will also serve on the Audit, Compensation, and Governance and Nominating Committees, bringing significant scientific and leadership expertise to the company.
Key Highlights
- Matt Link resigned from FibroBiologics' Board of Directors, effective July 2, 2026.
- Dr. Kathleen Rubins appointed as a Class III director to the Board, effective July 8, 2026.
- Dr. Rubins will serve until the 2029 annual meeting of stockholders.
- She was also appointed to the Audit, Compensation, and Governance and Nominating Committees.
- Dr. Rubins is the Founding Director of the Trivedi Institute for Space and Global Biomedicine.
- She is a retired NASA astronaut, microbiologist, and genomics scientist.
- Dr. Rubins will receive compensation consistent with other non-employee directors.
Price Impact
More from FBLG